logo

Cns Pharmaceuticals Inc (CNSP) Stock: A Year of Stock Market Ups and Downs

VIPS stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Cns Pharmaceuticals Inc’s current trading price is -99.64% away from its 52-week high, while its distance from the 52-week low is 15.00%. The stock’s price range over this period has fluctuated between $0.09 and $29.00. The company, operating within the financial sector, had a trading volume of approximately 29.79 million for the day, which was noticeably higher than the average daily share volume of 16.49 million over the last 3 months.

The market performance of Cns Pharmaceuticals Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $29.00 on 01/25/24, while the lowest value for the same duration was $0.09 on 01/23/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Cns Pharmaceuticals Inc (CNSP) has experienced a quarterly decline of -32.48% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.08M and boasts a workforce of 5 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.1233, with a change in price of -0.0412. Similarly, Cns Pharmaceuticals Inc recorded 16,782,500 in trading volume during the last 100 days, posting a change of -28.03%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CNSP stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.

CNSP Stock Stochastic Average

Today, Cns Pharmaceuticals Inc’s raw stochastic average for the past 50 days stands at 19.52%, indicating a rise from the raw stochastic average of the last 20 days, which was 19.52%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 10.78% and 8.18% respectively.

CNSP Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price decrease of -12.13%. However, over the past six months, we’ve seen a stronger performance of -90.20%. The price of CNSP leaped by -2.04% over the last 30 days. And in the last five days, it has fallen by -2.76%.

Most Popular